FDA Approves First-Ever Treatment for Hepatitis Delta

After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis.

This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.